47 Results

People

  1. Houghton
    Houghton
  2. Allison
    Allison
  3. Wolchok
    Wolchok
  4. Old
    Old
  5. Sadelain
    Sadelain
  6. Guevara Patino
    Guevara Patino
  7. Perales
    Perales
  8. Curran
    Curran
  9. Engelhorn
    Engelhorn
  10. Gansbacher
    Gansbacher

Groups

  1. Department of Medicine (23)
  2. Sloan Kettering Institute Faculty (23)
  3. GSK Faculty (20)
  4. Immunology Program Faculty (18)
  5. Solid Tumor Oncology Division (15)
  6. Center for Hematologic Malignancies (14)
  7. Hematologic Malignancies, Division of (14)
  8. Melanoma and Immunotherapeutics Service (12)
  9. Hematologic Malignancies Research (8)
  10. Molecular Pharmacology and Chemistry Program Faculty (8)
  1. "tumor rejection"
Formats
  1. Journal Article (47)
Groups
  1. Department of Medicine (23)
  2. Sloan Kettering Institute Faculty (23)
  3. GSK Faculty (20)
  4. Immunology Program Faculty (18)
  5. Solid Tumor Oncology Division (15)
  6. Center for Hematologic Malignancies (14)

More Groups

People
  1. Alan Houghton (17)
  2. Jedd Wolchok (11)
  3. James Allison (9)
  4. Lloyd Old (7)
  5. Michel Sadelain (7)
  6. Jose Guevara Patino (6)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2018 (3)
  4. 2015 (1)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publications
  1. Clinical Cancer Research (7)
  2. Proceedings of the National Academy of Sciences of the United States of America (6)
  3. Journal of Experimental Medicine (5)
  4. Cancer Research (3)
  5. Blood (2)
  6. Journal of Clinical Investigation (2)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. National Academy of Sciences (6)
  3. Rockefeller University Press (5)
  4. Nature Publishing Group (4)
  5. Elsevier Inc. (3)
  6. American Society for Clinical Investigation (2)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production
    Journal Article

    Curran, M. A.; Kim, M.; Montalvo, W.; Al Shamkhani, A.; Allison, J. P.
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals
    Journal Article

    Mitsui, J.; Nishikawa, H.; Muraoka, D.; Wang, L.; Noguchi, T.; Sato, E.; Kondo, S.; Allison, J. P.; Sakaguchi, S.; Old, L. J.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
    Journal Article

    Markley, J. C.; Sadelain, M.
    Blood (2010)

    Fulltext@MSK | Save
  • PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
    Journal Article

    Curran, M. A.; Montalvo, W.; Yagita, H.; Allison, J. P.
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save
  • Tumor-specific crosslinking of GITR as costimulation for immunotherapy
    Journal Article

    Burckhart, T.; Thiel, M.; Nishikawa, H.; Wüest, T.; Muller, D.; Zippelius, A.; Ritter, G.; Old, L.; Shiku, H.; Renner, C.
    Journal of Immunotherapy (2010)

    Fulltext@MSK | Save
  • The immunologic aspects of poxvirus oncolytic therapy
    Journal Article

    Worschech, A.; Haddad, D.; Stroncek, D. F.; Wang, E.; Marincola, F. M.; Szalay, A. A.
    Cancer Immunology, Immunotherapy (2009)

    Fulltext@MSK | Save
  • Cancer immunotherapy: Co-stimulatory agonists and co-inhibitory antagonists
    Journal Article

    Peggs, K. S.; Quezada, S. A.; Allison, J. P.
    Clinical and Experimental Immunology (2009)

    Fulltext@MSK | Save
  • Immune rejection of mouse tumors expressing mutated self
    Journal Article

    Duan, F.; Lin, Y.; Liu, C.; Engelhorn, M. E.; Cohen, A. D.; Curran, M.; Sakaguchi, S.; Merghoub, T.; Terzulli, S.; Wolchok, J. D.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
    Journal Article

    Quezada, S. A.; Peggs, K. S.; Simpson, T. R.; Shen, Y.; Littman, D. R.; Allison, J. P.
    Journal of Experimental Medicine (2008)

    Fulltext@MSK | Save
  • T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
    Journal Article

    Stephan, M. T.; Ponomarev, V.; Brentjens, R. J.; Chang, A. H.; Dobrenkov, K. V.; Heller, G.; Sadelain, M.
    Nature Medicine (2007)

    Fulltext@MSK | Save